Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Ranolazine selectively blocks persistent current evoked by epilepsy-associated Naν1.1 mutations.

British journal of pharmacology - 1 Nov 2010

Kahlig Kristopher M, Lepist Irene, Leung Kwan, Rajamani Sridharan, George Alfred L

Abstract excerpt

BACKGROUND AND PURPOSE: Mutations of SCN1A, the gene encoding the pore-forming subunit of the voltage-gated sodium channel Na(V) 1.1, have been associated with a spectrum of genetic epilepsies and a familial form of migraine. Several mutant Na(V) 1.1 channels exhibit increased persistent current...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epilepsy
Share to NAV1.1 Voltage-Gated Sodium Channel
Share to Nerve Tissue Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Piperazines

Share to Rats, Sprague-Dawley

Share to Sodium Channel Blockers

Share to Sodium Channels

Source

Open in PubMed Open full text

Identifiers

PMID: 20735403
DOI: 10.1111/j.1476-5381.2010.00976.x
PMCID: PMC3000664

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20735403-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Ranolazine selectively blocks persistent current evoked by epilepsy-associated Naν1.1 mutations.PMID 20735403Read ↗

The novel sodium channel modulator GS-458967 (GS967) is an effective treatment in a mouse model of SCN8A encephalopathy.Semantic proximity Read ↗

Differential effects of sodium channel blockers on <i>SCN8A</i> gain-of-function variants associated with drug-responsive or -resistant epilepsySemantic proximity Read ↗

Effects of ranolazine on wild-type and mutant hNav1.7 channels and on DRG neuron excitability.Semantic proximity Read ↗

Y1767C, a novel SCN5A mutation, induces a persistent Na+ current and potentiates ranolazine inhibition of Nav1.5 channels.Semantic proximity Read ↗

Persistent human cardiac Na+ currents in stably transfected mammalian cells: Robust expression and distinct open-channel selectivity among Class 1 antiarrhythmics.Semantic proximity Read ↗

How do mutant Nav1.1 sodium channels cause epilepsy?Semantic proximity Read ↗

Na <sub>V</sub> 1.6 inhibition drives the efficacy of voltage-gated sodium channel inhibitors to prevent electrically induced seizures in both wild type and <i> Scn8a <sup>N1768D/+</sup> </i> gain-of-function miceSemantic proximity Read ↗

R1617Q epilepsy mutation slows NaV 1.6 sodium channel inactivation and increases the persistent current and neuronal firing.Semantic proximity Read ↗

Late sodium current blocker GS967 inhibits persistent currents induced by familial hemiplegic migraine type 3 mutations of the SCN1A gene.Semantic proximity Read ↗

Single-channel properties of human NaV1.1 and mechanism of channel dysfunction in SCN1A-associated epilepsy.Semantic proximity Read ↗

State- and use-dependent block of muscle Nav1.4 and neuronal Nav1.7 voltage-gated Na+ channel isoforms by ranolazine.Semantic proximity Read ↗

Resurgent and Gating Pore Currents Induced by De Novo SCN2A Epilepsy MutationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.